Cite
APA Citation
Chihara, D., Westin, J. R., Miranda, R. N., Cheah, C. Y., Oki, Y., Turturro, F., Romaguera, J. E., Neelapu, S. S., Nastoupil, L. J., Fayad, L. E., Rodriguez, M. A., Fowler, N. H., Orlowski, R. Z., Wang, M., Hagemeister, F. B., Medeiros, L. J., & Fanale, M. A. (2017). dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma. British journal of haematology, 179, 503–506. http://access.bl.uk/ark:/81055/vdc_100053334368.0x00005d